相似文献
1
Comparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasma.
J Alzheimers Dis. 2010;21(3):769-73. doi: 10.3233/JAD-2010-100456.
2
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.
Arch Neurol. 2009 Feb;66(2):190-9. doi: 10.1001/archneurol.2008.565.
3
Paper-based electrochemiluminescence sensor for highly sensitive detection of amyloid-β oligomerization: Toward potential diagnosis of Alzheimer's disease.
Theranostics. 2018 Mar 11;8(8):2289-2299. doi: 10.7150/thno.23483. eCollection 2018.
4
Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
J Alzheimers Dis. 2020;74(4):1285-1294. doi: 10.3233/JAD-200046.
5
Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system.
Mol Neurodegener. 2011 Nov 8;6:76. doi: 10.1186/1750-1326-6-76.
6
A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
Alzheimers Res Ther. 2016 Dec 15;8(1):58. doi: 10.1186/s13195-016-0225-7.
7
An electrochemical peptide-based biosensor for the Alzheimer biomarker amyloid-β using a microporous gold nanostructure.
Mikrochim Acta. 2019 Nov 12;186(12):766. doi: 10.1007/s00604-019-3903-x.
8
Plasma amyloid-β oligomers level is a biomarker for Alzheimer's disease diagnosis.
Biochem Biophys Res Commun. 2012 Jul 13;423(4):697-702. doi: 10.1016/j.bbrc.2012.06.017. Epub 2012 Jun 12.
9
Electrochemical detection of β-amyloid peptides on electrode covered with N-terminus-specific antibody based on electrocatalytic O2 reduction by Aβ(1-16)-heme-modified gold nanoparticles.
Biosens Bioelectron. 2013 Nov 15;49:231-5. doi: 10.1016/j.bios.2013.05.028. Epub 2013 May 27.
10
Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
J Alzheimers Dis. 2017;58(1):23-35. doi: 10.3233/JAD-161116.
引用本文的文献
1
Relevance of plasma biomarkers to pathologies in Alzheimer's disease, Parkinson's disease and frontotemporal dementia.
Sci Rep. 2022 Oct 26;12(1):17919. doi: 10.1038/s41598-022-22647-6.
2
Graphene based electrochemical immunosensor for the ultra-sensitive label free detection of Alzheimer's beta amyloid peptides Aβ(1-42).
Nanoscale Adv. 2021 Feb 20;3(8):2295-2304. doi: 10.1039/d0na00801j. eCollection 2021 Apr 20.
3
Assessment of High Risk for Alzheimer's Disease Using Plasma Biomarkers in Subjects with Normal Cognition in Taiwan: A Preliminary Study.
J Alzheimers Dis Rep. 2021 Oct 21;5(1):761-770. doi: 10.3233/ADR-210310. eCollection 2021.
4
A Sensitive and Cost-Effective Chemiluminescence ELISA for Measurement of Amyloid-β 1-42 Peptide in Human Plasma.
J Alzheimers Dis. 2020;78(3):1237-1244. doi: 10.3233/JAD-200861.
5
Immunomagnetic Reduction Detects Plasma Aβ Levels as a Potential Dominant Indicator Predicting Cognitive Decline.
Neurol Ther. 2020 Dec;9(2):435-442. doi: 10.1007/s40120-020-00215-2. Epub 2020 Oct 22.
6
Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients.
Front Aging Neurosci. 2020 Sep 2;12:272. doi: 10.3389/fnagi.2020.00272. eCollection 2020.
7
Effect of Times to Blood Processing on the Stability of Blood Proteins Associated with Dementia.
Dement Geriatr Cogn Disord. 2020;49(3):303-311. doi: 10.1159/000509358. Epub 2020 Aug 12.
8
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) study.
Alzheimers Dement (Amst). 2020 Jun 30;12(1):e12039. doi: 10.1002/dad2.12039. eCollection 2020.
9
Human plasma biomarker responses to inhalational general anaesthesia without surgery.
Br J Anaesth. 2020 Sep;125(3):282-290. doi: 10.1016/j.bja.2020.04.085. Epub 2020 Jun 11.
10
Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome.
Alzheimers Dement (Amst). 2020 May 21;12(1):e12033. doi: 10.1002/dad2.12033. eCollection 2020.
本文引用的文献
1
Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia.
Nat Neurosci. 2009 Nov;12(11):1361-3. doi: 10.1038/nn.2432. Epub 2009 Oct 18.
2
Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study.
Neurology. 2009 Sep 15;73(11):847-53. doi: 10.1212/WNL.0b013e3181b78448.
3
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.
Exp Neurol. 2010 Jun;223(2):366-70. doi: 10.1016/j.expneurol.2009.07.024. Epub 2009 Aug 5.
4
ELISA and multiplex technologies for cytokine measurement in inflammation and aging research.
J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):879-84. doi: 10.1093/gerona/63.8.879.
5
Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.
Neuromolecular Med. 2008;10(3):195-207. doi: 10.1007/s12017-008-8035-0. Epub 2008 Jun 10.
6
Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.
Neurobiol Aging. 2010 Mar;31(3):357-67. doi: 10.1016/j.neurobiolaging.2008.03.027. Epub 2008 May 19.
7
Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families.
Neurology. 2008 Feb 19;70(8):596-606. doi: 10.1212/01.WNL.0000278386.00035.21. Epub 2007 Oct 3.
8
Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
J Neurochem. 2007 Oct;103(1):334-45. doi: 10.1111/j.1471-4159.2007.04759.x. Epub 2007 Jul 10.
9
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
Arch Neurol. 2007 Mar;64(3):354-62. doi: 10.1001/archneur.64.3.354.
10
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.
Mol Psychiatry. 2007 Jul;12(7):671-80. doi: 10.1038/sj.mp.4001967. Epub 2007 Mar 6.
Zotero 插件